131 related articles for article (PubMed ID: 12640715)
1. [Detection of P-170 and treatment with berbamine in primary acute leukemia].
Xu L; Zhao XY; Wu D
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Feb; 32(1):67-8. PubMed ID: 12640715
[No Abstract] [Full Text] [Related]
2. Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcome.
Goasguen JE; Lamy T; Bergeron C; Ly Sunaram B; Mordelet E; Gorre G; Dossot JM; Le Gall E; Grosbois B; Le Prisé PY; Fauchet R
Leuk Lymphoma; 1996 Nov; 23(5-6):567-76. PubMed ID: 9031088
[TBL] [Abstract][Full Text] [Related]
3. The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study.
Farawela HM; Khorshied MM; Kassem NM; Kassem HA; Zawam HM
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1323-30. PubMed ID: 24804815
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia.
Albertioni F; Gruber A; Areström I; Vitols S
Med Oncol; 1995 Jun; 12(2):79-86. PubMed ID: 8535665
[TBL] [Abstract][Full Text] [Related]
5. P-gp expression and Rh 123 efflux assay have no impact on survival in Egyptian pediatric acute lymphoblastic leukemia patients.
Kamel AM; El-Sharkawy N; Yassin D; Shaaban K; Hussein H; Sidhom I; Abo El-Naga S; Ameen M; El-Hattab O; Aly El-Din NH
J Egypt Natl Canc Inst; 2005 Sep; 17(3):165-72. PubMed ID: 16799654
[TBL] [Abstract][Full Text] [Related]
6. Study of expression and functional activity of P-GP membrane glycoprotein in children with acute leukemia.
Shman TV; Savitskii VP; Potapnev MP; Aleinikova OV
Bull Exp Biol Med; 2006 Jun; 141(6):727-30. PubMed ID: 17364061
[TBL] [Abstract][Full Text] [Related]
7. MRP1 polymorphisms (T2684C, C2007T, C2012T, and C2665T) are not associated with multidrug resistance in leukemic patients.
Mahjoubi F; Akbari S; Montazeri M; Moshyri F
Genet Mol Res; 2008; 7(4):1369-74. PubMed ID: 19065772
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of a MDR1 transcript for prediction of drug resistance in acute leukemia.
Fujimaki S; Funato T; Harigae H; Fujiwara J; Kameoka J; Meguro K; Kaku M; Sasaki T
Clin Chem; 2002 Jun; 48(6 Pt 1):811-7. PubMed ID: 12028995
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia.
Swerts K; de Moerloose B; Dhooge C; Noens L; Laureys G; Benoit Y; Philippé J
Leuk Lymphoma; 2004 Nov; 45(11):2221-8. PubMed ID: 15512810
[TBL] [Abstract][Full Text] [Related]
10. Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance.
Kuwazuru Y; Yoshimura A; Hanada S; Utsunomiya A; Makino T; Ishibashi K; Kodama M; Iwahashi M; Arima T; Akiyama S
Cancer; 1990 Sep; 66(5):868-73. PubMed ID: 1974821
[TBL] [Abstract][Full Text] [Related]
11. Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein pump in leukaemic cells.
Hegewisch-Becker S; Faltz C; Hossfeld DK
Eur J Haematol; 1996; 56(1-2):12-22. PubMed ID: 8599988
[TBL] [Abstract][Full Text] [Related]
12. Analysis of MDR1 and MDR3 multidrug resistance gene expression and amplification in consecutive samples in patients with acute leukaemias.
MacFarland A; Dawson AA; Pearson CK
Leuk Lymphoma; 1995 Sep; 19(1-2):135-40. PubMed ID: 8574159
[TBL] [Abstract][Full Text] [Related]
13. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in acute lymphoblastic leukemia.
Fenneteau O; Marie JP; Lescoeur B; Vilmer E; Schlegel N
Blood; 1993 Dec; 82(12):3787-9. PubMed ID: 7903172
[No Abstract] [Full Text] [Related]
14. Drug resistance in hematologic malignancies.
Marie JP
Curr Opin Oncol; 2001 Nov; 13(6):463-9. PubMed ID: 11673686
[TBL] [Abstract][Full Text] [Related]
15. Does modulation of P-glycoprotein have clinical relevance in pediatric acute myeloid leukemia?
Zwaan CM; den Boer ML; Kazemier KM; Hählen K; Loonen AH; Reinhardt D; Creutzig U; Kaspers GJ; Pieters R
Blood; 2006 Jun; 107(12):4975-6; author reply 4976-7. PubMed ID: 16754781
[No Abstract] [Full Text] [Related]
16. [The clinical significance of multidrug resistance associated protein(MRP) gene expression in acute leukemia].
Wang F; Dong Z; Luo J
Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):63-6. PubMed ID: 10921103
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group.
O'Brien MM; Lacayo NJ; Lum BL; Kshirsagar S; Buck S; Ravindranath Y; Bernstein M; Weinstein H; Chang MN; Arceci RJ; Sikic BI; Dahl GV
Pediatr Blood Cancer; 2010 May; 54(5):694-702. PubMed ID: 20209646
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia.
Ogretmen B; Barredo JC; Safa AR
J Pediatr Hematol Oncol; 2000; 22(1):45-9. PubMed ID: 10695821
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of multidrug resistance evaluated by means of the quantitative immunohistochemical detection of P-glycoprotein and the functional release of rhodamine 123.
Delville JP; Pradier O; Pauwels O; Van Onderbergen A; Kiss R; Feremans W; Capel P
Am J Hematol; 1995 Jul; 49(3):183-93. PubMed ID: 7604811
[TBL] [Abstract][Full Text] [Related]
20. The role of drug efflux pumps in acute myeloid leukemia.
van der Kolk DM; de Vries EG; Müller M; Vellenga E
Leuk Lymphoma; 2002 Apr; 43(4):685-701. PubMed ID: 12153153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
